StockNews.com Upgrades Xenon Pharmaceuticals (NASDAQ:XENE) to “Hold”
Xenon Pharmaceuticals (NASDAQ:XENE – Get Free Report) was upgraded by analysts at StockNews.com from a “sell” rating to a “hold” rating in a research report issued on Tuesday. A number of other equities research analysts have also recently commented on XENE. Royal Bank of Canada cut their target price on Xenon Pharmaceuticals from $58.00 to […]
Xenon Pharmaceuticals (NASDAQ:XENE – Get Free Report) was upgraded by analysts at StockNews.com from a “sell” rating to a “hold” rating in a research report issued on Tuesday. A number of other equities research analysts have also recently commented on XENE. Royal Bank of Canada cut their target price on Xenon Pharmaceuticals from $58.00 to […]
